Prediabetes, dyslipidemia, arterial hypertension, non-alcoholic fatty liver disease: at Valbiotis, our research targets the main metabolic and cardiovascular risk factors.
Prediabetes, dyslipidemia, arterial hypertension, non-alcoholic fatty liver disease: at Valbiotis, our research targets the main metabolic and cardiovascular risk factors.
Four plant-based active substances in clinical development to reduce the risk of metabolic and cardiovascular diseases.
